Vor Biopharma
VOR
VOR
71 hedge funds and large institutions have $188M invested in Vor Biopharma in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
+12
Holders Change %
+20.34%
% of All Funds
1.12%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
23
Increased
16
Reduced
15
Closed
11
Calls
$105K
Puts
$15K
Net Calls
+$90K
Net Calls Change
-$7K
Top Buyers
| 1 |
BlackRock
New York
|
$6.69M |
| 2 |
State Street
Boston,
Massachusetts
|
$1.94M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
$2.23M |
| 4 |
Northern Trust
Chicago,
Illinois
|
$1.08M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$5.29M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
6CM
76
683 Capital Management
New York
| – | -$137K | -25,419 | Closed |
|
|
BFM
77
Boothbay Fund Management
New York
| – | -$105K | -19,536 | Closed |
|
78
Walleye Capital
New York
| – | -$88.6K | -16,463 | Closed |
|
|
DC
79
Diametric Capital
Boston,
Massachusetts
| – | -$69.4K | -12,902 | Closed |
|
80
Balyasny Asset Management
Chicago,
Illinois
| – | -$67.9K | -12,627 | Closed |
|
81
D.E. Shaw & Co
New York
| – | -$61.8K | -11,478 | Closed |
|
82
Man Group
London,
United Kingdom
| – | -$135K | – | – |
|